| Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia. |
28699174
|
Gu F, Zhang H, Hyland PL, Berndt S, Gapstur SM, Wheeler W, Ellipse Consortium T, Amos CI, Bezieau S, Bickeböller H, Brenner H, Brennan P, Chang-Claude J, Conti DV, Doherty JA, Gruber SB, Harrison TA, Hayes RB, Hoffmeister M, Houlston RS, Hung RJ, Je… |
Int J Cancer |
2017 |
PLCO |
| ConvNet-Based Localization of Anatomical Structures in 3-D Medical Images. |
28252392
|
de Vos BD, Wolterink JM, de Jong PA, Leiner T, Viergever MA, Isgum I |
IEEE Trans Med Imaging |
2017 |
NLST |
| Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. |
25601300
|
Breyer BN, Huang WY, Rabkin CS, Alderete JF, Pakpahan R, Beason TS, Kenfield SA, Mabie J, Ragard L, Wolin KY, Grubb RL, Andriole GL, Sutcliffe S |
BJU Int. |
2016 |
PLCO |
| Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. |
27009070
|
Patz EF, Greco E, Gatsonis C, Pinsky P, Kramer BS, Aberle DR |
Lancet Oncol. |
2016 |
NLST |
| Did death certificates and a death review process agree on lung cancer cause of death in the National Lung Screening Trial? |
27006427
|
Marcus PM, Doria-Rose VP, Gareen IF, Brewer B, Clingan K, Keating K, Rosenbaum J, Rozjabek HM, Rathmell J, Sicks J, Miller AB |
Clin Trials |
2016 |
NLST |
| CANARY Risk Management of Adenocarcinoma: The Future of Imaging? |
|
Finbar Foley
, Srinivasan Rajagopalan
, Sushravya M. Raghunath
, Jennifer M. Boland
, Ronald A. Karwoski
, Fabien Maldonado
, Brian J. Bartholmai
, Tobias Peikert
, |
j.semtcsv |
2016 |
NLST |
| Normative reference values of thoracic aortic diameter in American College of Radiology Imaging Network (ACRIN 6654) arm of National Lung Screening Trial. |
27203287
|
McComb BL, Munden RF, Duan F, Jain AA, Tuite C, Chiles C |
Clin Imaging |
2016 |
NLST |
| Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening. |
27179989
|
Katki HA, Kovalchik SA, Berg CD, Cheung LC, Chaturvedi AK |
JAMA |
2016 |
NLST |
| The Potential Clinical, Resource Use, And Fiscal Impacts of Lung-Rads To Inform Lung Cancer Screening In Medicare |
|
J. Roth, S.D. Sullivan, S. Ramsey, B. Goulart |
Val Health |
2016 |
NLST |
| Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules. |
27378239
|
Yip R, Yankelevitz DF, Hu M, Li K, Xu DM, Jirapatnakul A, Henschke CI |
Radiology |
2016 |
NLST |
| Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. |
27387658
|
Balekian AA, Tanner NT, Fisher JM, Silvestri GA, Gould MK |
Ann Am Thorac Soc |
2016 |
NLST |
| Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration. |
27330355
|
Evans WK, Flanagan WM, Miller AB, Goffin JR, Memon S, Fitzgerald N, Wolfson MC |
Curr Oncol |
2016 |
NLST |
| Prediction of lung cancer incidence on the low-dose computed tomography arm of the National Lung Screening Trial: A dynamic Bayesian network. |
27664507
|
Petousis P, Han SX, Aberle D, Bui AA |
Artif Intell Med |
2016 |
NLST |
| Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST). |
27925181
|
Goldwasser DL |
Int. J. Cancer |
2016 |
NLST |
| The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial Cohort. |
27740906
|
White CS, Dharaiya E, Campbell E, Boroczky L |
Radiology |
2016 |
NLST |
| Evaluating Long-Term Outcomes via Computed Tomography in Lung Cancer Screening |
|
Dongfeng Wu, Ruiqi Liu, Beth Levitt, Tom Riley, Kathy B. Baumgartner |
J Biom Biostat |
2016 |
NLST |
| Prognostic Significance of a Negative Prostate Biopsy: An Analysis of Subjects Enrolled in a Prostate Cancer Screening Trial. |
27836710
|
Lewicki P, Shoag J, Golombos DM, Oromendia C, Ballman KV, Halpern JA, Stone BV, O'Malley P, Barbieri CE, Scherr DS |
J. Urol. |
2016 |
PLCO |
| Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel. |
27810449
|
Kim EH, Andriole GL, Crawford ED, Sjoberg DD, Assel M, Vickers AJ, Lilja H |
J. Urol. |
2016 |
PLCO |
| Reevaluating PSA Testing Rates in the PLCO Trial. |
27144870
|
Shoag JE, Mittal S, Hu JC |
N. Engl. J. Med. |
2016 |
PLCO |
| Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. |
27149646
|
Bradley MC, Black A, Freedman AN, Barron TI |
Cancer |
2016 |
PLCO |
